Beijing Suncadia Pharmaceuticals Co., Ltd

Primary Objective To evaluate the efficacy of HRS-5346 in adult subjects at high risk for cardiovascular events with elevated lipoprotein (a) [Lp(a)]. Secondary Objectives To evaluate the safety and tolerability of HRS-5346 in adult subjects at high risk for cardiovascular events with elevated lipoprotein (a) [Lp(a)]; To evaluate the response of HRS-5346 in adult subjects at high risk for cardiovascular events with elevated lipoprotein (a) [Lp(a)]; To evaluate the pharmacokinetic (PK) characteristics of HRS-5346 in adult subjects at high risk for cardiovascular events with elevated lipoprotein (a) [Lp(a)].

Main purpose 1. To evaluate the effectiveness of HRS8179 for injection in preventing and treating severe cerebral edema after large-area cerebral infarction Secondary purpose 1. To evaluate the other effectiveness of HRS8179 for injection in preventing and treating severe cerebral edema after large-area cerebral infarction 2. To evaluate the safety of HRS8179 for injection in preventing and treating severe cerebral edema after large-area cerebral infarction